ImmunoPrecise Antibodies Ltd. Files 6-K for Meeting Notice
Ticker: HYFT · Form: 6-K · Filed: Aug 1, 2025 · CIK: 1715925
Sentiment: neutral
Topics: 6-K, meeting-notice, corporate-action
TL;DR
IPA filed a 6-K for a meeting notice on Aug 1, 2025. Shareholders should pay attention.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on August 1, 2025, to report a Notice of Meeting and Record Date dated August 1, 2025. The company, with its principal executive office in Austin, Texas, is a foreign private issuer filing annual reports under Form 20-F.
Why It Matters
This filing indicates upcoming corporate actions or decisions requiring shareholder participation, such as a meeting, which could impact the company's strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine procedural notice and does not contain information about significant financial changes or operational risks.
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Registrant
- August 1, 2025 (date) — Filing date and notice date
- Jennifer Bath (person) — Signatory for the company
- Austin, Texas (location) — Principal executive office location
FAQ
What is the purpose of the Notice of Meeting and Record Date filed on August 1, 2025?
The filing is a Form 6-K which includes Exhibit 99.1, a Notice of Meeting and Record Date dated August 1, 2025, indicating upcoming shareholder actions.
Which form does ImmunoPrecise Antibodies Ltd. use for its annual reports?
ImmunoPrecise Antibodies Ltd. indicates it files annual reports under Form 20-F.
Where are ImmunoPrecise Antibodies Ltd.'s principal executive offices located?
The principal executive offices are located at Industrious, 823 Congress Ave Suite 300, Austin, Texas 78701.
Who signed the Form 6-K on behalf of ImmunoPrecise Antibodies Ltd.?
The Form 6-K was signed by Jennifer Bath on behalf of ImmunoPrecise Antibodies Ltd.
What is the Commission File Number for ImmunoPrecise Antibodies Ltd.?
The Commission File Number for ImmunoPrecise Antibodies Ltd. is 001-39530.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 1, 2025 by Jennifer Bath regarding ImmunoPrecise Antibodies Ltd. (HYFT).